SEC Filing Details
Document Details
Form
Filing Date
Sep 25, 2020
Document Date
Sep 25, 2020
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
BioLineRx
Issuer
BioLineRx Ltd.
Press Releases View all
March 22, 2023
BioLineRx Reports 2022 Financial Results and Recent Corporate and Portfolio Updates
March 15, 2023
BioLineRx to Report 2022 Annual Financial Results on March 22, 2023